West Pharmaceutical Services | WST - Equity Capital And Reserves



West Pharmaceutical Services reported $2.93B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Align Technology USD 3.79B 57.74M Mar/2025
Avanos Medical USD 776.3M 63.1M Jun/2025
Baxter International USD 7.05B 90M Mar/2025
Becton, Dickinson and Co. USD 25.47B 231M Jun/2025
Charles River Laboratories USD 3.31B 119.03M Jun/2025
Cooper Companies USD 8.35B 64.9M Jul/2025
Dentsply International USD 1.96B 50M Jun/2025
Haemonetics USD 882.3M 61.46M Jun/2025
ICU Medical USD 2.12B 128.09M Jun/2025
Insulet USD 1.46B 132.2M Jun/2025
Integra LifeSciences USD 1.04B 485.48M Jun/2025
IQVIA Holdings USD 5.78B 199M Jun/2025
J&J USD 78.11B 6.62B Mar/2025
Medtronic USD 48.02B 1.36B Apr/2025
Merit Medical Systems USD 1.49B 59.62M Jun/2025
Neogen USD 2.07B 589.09M May/2025
Quidel USD 2.79B 204.5M Jun/2025
Repligen USD 1.99B 12.76M Mar/2025
Solventum Corp 3.64B 383M Jun/2025
STAAR Surgical USD 336.57M 13.4M Jun/2025
Terumo JPY 1.37T 536M Jun/2025
West Pharmaceutical Services USD 2.93B 246M Jun/2025